Enduring online program
2 contact hours (0.20 CEUs)
Prescribers with a DEA number and medical residents prescribing under a facility DEA number.
The purpose of New York State (NYS) Prescription Drug Overdose (PDO) Prevention Program is to advance and evaluate comprehensive state-level interventions for preventing prescription drug overuse, misuse, abuse, and overdose. Effective July 22, 2016, Public Health Law Article 33 §3309-a was updated to require prescribers with a Drug Enforcement Administration (DEA) number and medical residents prescribing under a facility DEA number to complete a minimum of a 3-hours of course work or training in pain management, palliative care and addiction. Included in the PDO Prevention Program objectives, is an educational component for provider. The education outreach program will focus on updating providers on the Centers for Disease Control and Prevention (CDC) Guidelines for Prescribing Opioids for Chronic Pain- United States, 2016 and the topics included in the educational mandate. You must complete both part I and part II of the Opioid Prescriber Training Program located on the right bar under home study programs, in order to meet the mandated legislation. Part I and part II of the program will provide 2.0 hours of CME (each) at no cost to the provider.
· Describe the appropriate considerations in managing a patient’s pain to prevent development of addiction
· Identify and evaluate risk factors for development of Substance Use Disorder
· Describe screening tools and processes that may be used to identify signs of addiction
· Evaluate patients seeking pain medication and discuss appropriate treatment approaches based on whether the patient can be identified as in chronic pain, addiction, both, or neither
Opioid Prescriber Training Part II covers four of the mandated topic areas:
This program contains a pre-test, video presentation, educational handout material, post-test, and a program evaluation. Credit will be awarded upon successful completion of this activity with a post-test score of 70% or better.
Richard D. Blondell, MD
University at Buffalo
Department of Family Medicine
Professor and Vice Chair for Addiction Medicine
Robert G. Wahler Jr., PharmD
Clinical Assistant Professor
Department of Pharmacy Practice
UB School of Pharmacy and Pharmaceutical Sciences
Clinical Pharmacy Services, Niagara Hospice, Inc
There is no fee associated with this program for prescribers.
Pharmacists are welcome to participate in this program for a nominal fee of $20.00 and ACPE accreditation has been awarded for this activity.
The program is supported by the Cooperative Agreement 1 NU17CE002742-01, funded by the Centers for Disease Control and Prevention and by the New York State Department of Health. The contents are solely the responsibility of the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.
NYS Department of Health Guidance Document:
Recommended Web Browsers:
How to Enable Cookies:
Please do not use Internet Explorer as your browser for this program.
Accreditation Types: AACME, ACPE and ADA/CERP
Accreditation for Pharmacists:
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based enduring activity has been assigned ACPE# 0044-0000-19-019-H01-P and will award 2 contact hours (0.20 CEUs) of continuing pharmacy education credit. Credit will be uploaded to the CPE Monitor to those who complete all components of this activity and achieve a successful score of 70% or greater on the post-test.
Initial release date: 2/25/2019
Expiration date: 8/31/2020
Certification for Physicians:
The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.
The University at Buffalo School Jacobs School of Medicine and Biomedical Sciences designates this Enduring Material activity, Course Code 9057A for a maximum of 2.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Please be sure to attest once you have completed the course at
Certification for Dentists:
UB Continuing Dental Education is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying qualified providers of continuing dental accreditation. ADA CERP does not approve or endorse individual courses or instructors, not does it imply acceptance of credit hours by boards of dentistry. UB Continuing Dental Education designates this activity for 2 continuing education credits.
Program Completion: Prescribers and Dentists you will receive via email your ACCME certificate or DDS certification of attendance and letter of completion within 48 hours.
(Please check your spam/junk email folder if you do not see it in your inbox.)
Pharmacists will receive via email the letter of completion and ACPE credit will be uploaded directly to the CPE Monitor.
The letter of completion will certify this educational activity meets the NYS mandated opioid training.
Please email firstname.lastname@example.org